How much GMP is in your cannabis medicine? by Martin Lane September 8, 2021April 26, 2024 At a time when the TGA is scrutinising the industry like never before, simply saying your […]
Products pass TGA tests with flying colours – but quality and compliance concerns remain by Rhys Cohen September 2, 2021April 26, 2024
D-Day approaches for New Zealand’s medicinal cannabis scheme by Martin Lane August 25, 2021April 26, 2024
Relief for CBD-only patients as study rules out risk of positive drug-driving test by Hannah Adler August 19, 2021April 26, 2024
A year of frustration but Cann Group vows to deliver for shareholders and consumers by Steve Jones August 12, 2021April 26, 2024
Labor’s last-minute intervention in Victoria’s cannabis inquiry only delays the inevitable by Rhys Cohen August 5, 2021April 26, 2024
From AFL to LGP: the journey into medicinal cannabis for Fleta Solomon by Steve Jones August 5, 2021April 26, 2024
The Green Room: what Colombia’s new flower export rules mean for Australia by Martin Lane July 26, 2021April 26, 2024
